Related Experiment Video
Updated: May 14, 2026

Enrichment of mRNA and Bisulfite-mRNA Library Preparation for Next-Generation Sequencing
Published on: July 7, 2023
Epitranscriptomic control of cancer: the emerging roles of m⁵C and ac⁴C RNA modifications
Xian Zhong1,2, Jianmei Mao3,4,5, Jiawei Zhang6
1Department of Medical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. zhongxian@zju.edu.cn.
Abstract:
Cytidine RNA modifications have emerged as key regulators of tumor cancer biology, linking transcriptional control to metabolic adaptation and immune evasion. Among them, 5-methylcytidine (m⁵C) and N⁴-acetylcytidine (ac⁴C) represent dynamic and functionally complementary epitranscriptomic marks that operate through distinct regulatory layers. m⁵C, catalyzed by the NSUN family methyltransferases, primarily stabilizes pro-tumorigenic transcripts, enhances glycolysis, and suppresses antitumor immunity through modulation of cytokine and checkpoint pathways. In parallel, ac⁴C, mediated by the acetyltransferase NAT10, fine-tunes translational efficiency and proteostasis, enabling tumor cells to adapt to metabolic and therapeutic stress. Together, these modifications cooperatively remodel the tumor immune microenvironment by driving macrophage polarization, T-cell exhaustion, and attenuation of interferon signaling, establishing a durable immunosuppressive niche. Notably, pharmacologic or genetic inhibition of m⁵C- and ac⁴C-modifying enzymes reverses malignant phenotypes and restores sensitivity to immune checkpoint and metabolic therapies. Elucidating this two-layer cytidine epitranscriptomic architecture unveils new epigenetic dimensions of tumor plasticity and offers promising avenues for precision RNA-targeted oncology.
Insights
Two key RNA modifications, 5-methylcytidine (m⁵C) and N⁴-acetylcytidine (ac⁴C), regulate tumor biology and immune evasion. Inhibiting their enzymes reverses cancer traits and improves therapy sensitivity.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- Cytidine RNA modifications are crucial in tumor biology, influencing gene expression, metabolism, and immune responses.
- 5-methylcytidine (m⁵C) and N⁴-acetylcytidine (ac⁴C) are dynamic epitranscriptomic marks with distinct roles in cancer progression.
Purpose of the Study:
- To investigate the complementary roles of m⁵C and ac⁴C in shaping the tumor microenvironment.
- To explore the therapeutic potential of targeting m⁵C- and ac⁴C-modifying enzymes in cancer.
Main Methods:
- Analysis of m⁵C and ac⁴C modifications and their associated enzymes (NSUNs and NAT10).
- Assessment of the impact of these modifications on gene expression, protein synthesis, and immune cell function.
- Pharmacologic and genetic inhibition studies to evaluate therapeutic efficacy.
Main Results:
- m⁵C stabilizes pro-tumorigenic transcripts, promotes glycolysis, and suppresses antitumor immunity.
- ac⁴C regulates translational efficiency and proteostasis, aiding tumor adaptation to stress.
- Together, m⁵C and ac⁴C create an immunosuppressive tumor microenvironment by affecting macrophages and T cells.
- Inhibition of m⁵C and ac⁴C pathways reversed malignant phenotypes and restored sensitivity to therapies.
Conclusions:
- Cytidine RNA modifications (m⁵C and ac⁴C) establish a two-layer epitranscriptomic architecture that drives tumor plasticity and immunosuppression.
- Targeting these RNA modification pathways offers a promising strategy for precision RNA-targeted oncology.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Master Transcription Regulators

